Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • A Study of BMS-986504 with Drug Combination Compared to Placebo with Drug Combination in Patients with Advanced Non-Small Cell Lung Cancer Starting First Treatment

    Recruiting

    1 1 1
    Austria Belgium Bulgaria Czechia Denmark France +9
  • A study testing ASP5541 compared to abiraterone acetate in patients with advanced prostate cancer

    Recruiting

    1 1 1
    Investigated diseases:
    France Germany Italy Poland Spain
  • Study of luspatercept for patients with rare inherited anemias to reduce transfusion needs and improve hemoglobin levels

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France Italy
  • A Study of IMVT-1402 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy to Prevent Disease Relapse

    Recruiting

    Investigated drugs:
    Austria Belgium Bulgaria Denmark Estonia Finland +13
  • A Study of Mezagitamab Compared to Placebo for Adults with Chronic Primary Immune Thrombocytopenia

    Recruiting

    1 1
    Bulgaria Croatia Czechia France Germany Greece +6
  • Study of Different Dosing Schedules of Osimertinib in Patients with EGFR Mutated Advanced or Metastatic Non-Small Cell Lung Cancer

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium The Netherlands
  • A study comparing BNT323 with chemotherapy in patients with HER2-expressing recurrent endometrial cancer who received previous treatment

    Recruiting

    1 1 1 1
    Austria Belgium Czechia Denmark Finland France +9
  • Study of BNT314 and BNT327 with chemotherapy for patients with metastatic colorectal cancer

    Recruiting

    1 1
    Investigated drugs:
    Germany Spain
  • Study of MT-501 in patients with active Crohn’s Disease or Ulcerative Colitis: A Phase 2 safety and effectiveness trial

    Recruiting

    Investigated diseases:
    Belgium Bulgaria Croatia Czechia Germany Italy +2
  • Study of mezigdomide and elranatamab combination treatment for patients with relapsed or refractory multiple myeloma

    Recruiting

    1 1 1
    Germany Greece Norway Spain